Skip to content

Search Results

No Matching Results

    Recently Viewed

      Listening...

      HomeMedia CenterPress releases FinancialJohnson & Johnson to Host Investor Conference Call on Third-Quarter Results

      Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results

      Share Article
      share to

      NEW BRUNSWICK, N.J., Sept. 15, 2015 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, Oct. 13th, to review third-quarter results. Gary Pruden, Worldwide Chairman, Medical Devices; Dominic Caruso, Vice President, Finance and Chief Financial Officer and Louise Mehrotra, Vice President, Investor Relations, will host the call.

      Investors and other interested parties can access the webcast/conference call in the following ways:

      • The webcast is accessible at Johnson & Johnson’s website: www.investor.jnj.com. A webcast and podcast replay will be available approximately two hours after the conference call concludes.
      • By telephone: for both “listen-only” participants and those financial analysts who wish to take part in the question-and-answer portion of the call, the telephone dial-in number in the U.S. is 877-869-3847. For participants outside the U.S., the dial-in number is 201-689-8261.
      • A replay of the conference call will be available beginning at approximately 1:00 p.m. on Oct. 13, 2015, and ending at approximately 12:00 a.m. on Oct. 21, 2015. The replay dial-in number for U.S. participants is 877-660-6853. For participants outside the U.S., the replay dial-in number is 201-612-7415. The replay conference ID number for all callers is 13619952.
      • Presentation materials will be available on www.investor.jnj.com.
      • The press release will be available at 7:30 a.m. (Eastern Time) the morning of the conference call.

      About Johnson & Johnson

      Caring for the world, one person at a time, inspires and unites the people of Johnson & Johnson. We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people. Our approximately 127,000 employees at more than 265 Johnson & Johnson operating companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.

      SOURCE Johnson & Johnson

      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.